लोड हो रहा है...
Remyelinating Pharmacotherapies in Multiple Sclerosis
We have witnessed major successes in the development of effective immunomodulatory therapies capable of reducing adaptive immune-mediated myelin damage in MS over the last 30 years. However, until it is possible to prevent MS or initiate treatment before it has already caused lesions there is a need...
में बचाया:
| में प्रकाशित: | Neurotherapeutics |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Springer US
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722779/ https://ncbi.nlm.nih.gov/pubmed/28948533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0577-0 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|